These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 17172415)
1. Direct targeting of alphavbeta3 integrin on tumor cells with a monoclonal antibody, Abegrin. Mulgrew K; Kinneer K; Yao XT; Ward BK; Damschroder MM; Walsh B; Mao SY; Gao C; Kiener PA; Coats S; Kinch MS; Tice DA Mol Cancer Ther; 2006 Dec; 5(12):3122-9. PubMed ID: 17172415 [TBL] [Abstract][Full Text] [Related]
2. Production and characterization of a humanized single-chain antibody against human integrin alphav beta3 protein. Liu D; Wang C; Li C; Zhang X; Zhang B; Mi Z; An X; Tong Y J Biol Chem; 2011 Jul; 286(27):24500-7. PubMed ID: 21606501 [TBL] [Abstract][Full Text] [Related]
3. Modulating Tumor Immunity by Targeting Tumor Fibrotic Stroma and Angiogenic Vessels for Lung Cancer Treatment. Yuan Y; Mishra F; Li B; Peng G; Chan P; Yang J; Liu Z Cancers (Basel); 2024 Jul; 16(13):. PubMed ID: 39001545 [TBL] [Abstract][Full Text] [Related]
4. Integrin alpha(v)beta(3)-Targeted Cancer Therapy. Liu Z; Wang F; Chen X Drug Dev Res; 2008; 69(6):329-339. PubMed ID: 20628538 [TBL] [Abstract][Full Text] [Related]
5. A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or - dacarbazine in patients with stage IV metastatic melanoma. Hersey P; Sosman J; O'Day S; Richards J; Bedikian A; Gonzalez R; Sharfman W; Weber R; Logan T; Buzoianu M; Hammershaimb L; Kirkwood JM; Cancer; 2010 Mar; 116(6):1526-34. PubMed ID: 20108344 [TBL] [Abstract][Full Text] [Related]
6. Every step of the way: integrins in cancer progression and metastasis. Hamidi H; Ivaska J Nat Rev Cancer; 2018 Sep; 18(9):533-548. PubMed ID: 30002479 [TBL] [Abstract][Full Text] [Related]
7. Integrins in cancer: biological implications and therapeutic opportunities. Desgrosellier JS; Cheresh DA Nat Rev Cancer; 2010 Jan; 10(1):9-22. PubMed ID: 20029421 [TBL] [Abstract][Full Text] [Related]
8. The roles of integrin αvβ6 in cancer. Niu J; Li Z Cancer Lett; 2017 Sep; 403():128-137. PubMed ID: 28634043 [TBL] [Abstract][Full Text] [Related]
9. Antipodoplanin antibody enhances the antitumor effects of CTLA-4 blockade against malignant mesothelioma by natural killer cells. Yoneda H; Mitsuhashi A; Yoshida A; Ogino H; Itakura S; Nguyen NT; Nokihara H; Sato S; Shinohara T; Hanibuchi M; Abe S; Kaneko MK; Kato Y; Nishioka Y Cancer Sci; 2024 Feb; 115(2):357-368. PubMed ID: 38148492 [TBL] [Abstract][Full Text] [Related]
10. Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer. Testa A; Quaglia F; Naranjo NM; Verrillo CE; Shields CD; Lin S; Pickles MW; Hamza DF; Von Schalscha T; Cheresh DA; Leiby B; Liu Q; Ding J; Kelly WK; Hooper DC; Corey E; Plow EF; Altieri DC; Languino LR Matrix Biol; 2023 Dec; 124():49-62. PubMed ID: 37956856 [TBL] [Abstract][Full Text] [Related]
11. Mechanistic and Structural Features of PROTAC Ternary Complexes. Casement R; Bond A; Craigon C; Ciulli A Methods Mol Biol; 2021; 2365():79-113. PubMed ID: 34432240 [TBL] [Abstract][Full Text] [Related]
15. Small extracellular vesicles modulated by αVβ3 integrin induce neuroendocrine differentiation in recipient cancer cells. Quaglia F; Krishn SR; Daaboul GG; Sarker S; Pippa R; Domingo-Domenech J; Kumar G; Fortina P; McCue P; Kelly WK; Beltran H; Liu Q; Languino LR J Extracell Vesicles; 2020 May; 9(1):1761072. PubMed ID: 32922691 [TBL] [Abstract][Full Text] [Related]
16. Targeting the TMPRSS2/ERG fusion mRNA using liposomal nanovectors enhances docetaxel treatment in prostate cancer. Shao L; Kahraman N; Yan G; Wang J; Ozpolat B; Ittmann M Prostate; 2020 Jan; 80(1):65-73. PubMed ID: 31614005 [TBL] [Abstract][Full Text] [Related]
17. Are Integrins Still Practicable Targets for Anti-Cancer Therapy? Alday-Parejo B; Stupp R; Rüegg C Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31336983 [TBL] [Abstract][Full Text] [Related]
18. Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment. Harjunpää H; Llort Asens M; Guenther C; Fagerholm SC Front Immunol; 2019; 10():1078. PubMed ID: 31231358 [TBL] [Abstract][Full Text] [Related]
19. Integrin-targeted quantitative optoacoustic imaging with MRI correlation for monitoring a BRAF/MEK inhibitor combination therapy in a murine model of human melanoma. Kazmierczak PM; Burton NC; Keinrath G; Hirner-Eppeneder H; Schneider MJ; Eschbach RS; Heimer M; Solyanik O; Todica A; Reiser MF; Ricke J; Cyran CC PLoS One; 2018; 13(10):e0204930. PubMed ID: 30281669 [TBL] [Abstract][Full Text] [Related]